Tafalgie Therapeutics
PrivateLast Round
Series A
Sep 15, 2025
Total Funding Raised
$16.82M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Tafalgie Therapeutics is a biotechnology company that develops non-opioid, pain-relieving peptide therapeutics for the treatment of acute and chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tafalgie Therapeutics Comparables
Compare Tafalgie Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Latigo Biotherapeutics | 81% | |
| Akelos Inc. | 80% | |
| Algiax Pharmaceuticals | 80% | |
Tafalgie Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 15, 2025 | ||||
| Grant | Nov 1, 2023 |
Tafalgie Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors increased 38% MoM, reaching 1.2K.
- Mar 1, 2026
Monthly visitors grew 78% MoM.
Tafalgie Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tafalgie Therapeutics's valuation, stock price, and market status.